New research suggests that herpes simplex virus-1 (HSV-1) may play a role in the development of Alzheimer’s disease, offering fresh insight into how infections affect the brain.
The study also revealed that tau protein—long considered a harmful hallmark of Alzheimer’s—may initially serve a protective role against viral infections, raising new questions about how this protein functions in brain health.
Understanding the Growing Impact of Alzheimer’s Disease
With dementia cases projected to reach 153 million globally by 2050, researchers are working to identify the health conditions that increase the risk of Alzheimer’s disease—the most common form of dementia.
According to Dr. Or Shemesh, assistant professor at the University of Pittsburgh and senior author of the study published in Cell Reports, identifying risk factors is critical:
“By understanding the risk factors, researchers can develop strategies to mitigate these risks, potentially delaying or preventing the onset of Alzheimer’s. Additionally, this knowledge contributes to the broader understanding of the disease’s mechanisms, which can lead to the discovery of novel therapeutic targets and improved diagnostic tools.”
HSV-1 and Tau Protein: A Surprising Connection
Alzheimer’s is typically diagnosed by the presence of:
- Beta-amyloid plaques outside brain cells
- Tau tangles inside brain cells
Traditionally, tau buildup has been seen as a damaging process. However, Shemesh’s research found that:
- HSV-1 proteins were present in postmortem brain samples of people with Alzheimer’s.
- Viral proteins increased as the disease progressed and appeared in the same brain regions as tau.
- In lab models, HSV-1 infection triggered an increase in tau proteins.
Interestingly, instead of harming neurons immediately, the modified tau appeared to protect brain cells, lowering viral activity and reducing neuron death after HSV-1 infection.
The Brain’s Immune Response
The study also uncovered involvement of the cGAS-STING pathway, an immune defense mechanism in the brain:
- When activated, this pathway increased tau modification.
- When blocked, tau modification stopped.
This suggests that tau may be part of the brain’s natural immune response, not just a marker of disease.
What This Means for Alzheimer’s Treatment
These findings could open the door to new therapies for Alzheimer’s disease. Instead of only trying to block tau buildup, treatments might:
- Enhance tau’s protective immune function without allowing harmful aggregation.
- Strengthen the brain’s innate defenses against viral infections like HSV-1.
- Lead to targeted therapies that mimic tau’s protective effects while reducing its damaging role in neurofibrillary tangle formation.
Shemesh and his team plan to explore tau’s role further, study interactions with other pathogens, and test therapies that could harness tau’s beneficial effects.
Supporting Alzheimer’s and Dementia Care
While researchers continue to make progress, Alzheimer’s remains a serious challenge for millions of families. At Personal Senior Care Homes, we have been providing compassionate, personalized care for residents with Alzheimer’s disease and other forms of dementia for many years.
We are committed to sharing the latest research and resources to help families stay informed and supported.
Contact Steve Brock at 513-505-5018 for more information or to schedule a tour of our homes.
This article is based on research reported by Medical News Today.